Depending upon the pricing structure & availability of Saxagliptin (Onglyza) the pill should do well in India, as India happens to be perhaps the capital of diabetics.
India is the perhaps the first Asian country where saxagliptin is available, launched by Bristol-Myers Squibb and AstraZeneca.
- Onglyza Information for Consumers
- Onglyza Information for Healthcare Professionals (includes dosage details)
- Side Effects of Onglyza (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 6 May 2010 • 1 answer
Posted 29 Dec 2010 • 1 answer
Posted 10 Jan 2011 • 1 answer
Posted 23 Jul 2011 • 1 answer
Posted 31 Aug 2011 • 2 answers